跳至主要内容
临床试验/EUCTR2009-012071-10-IT
EUCTR2009-012071-10-IT进行中(未招募)不适用

Rivastigmine in the treatment of Sleep REM Behaviour Disorder (RBD) and Hallucinations in Parkinsonism: a Clinical and Polysomnographic study? - ND

POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 个研究点开始时间: 2009年5月29日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Clinical and Polysomnographic diagnosis of RBD (REM Sleep Behavior Disorders) based on the ICD (International Classification of Sleep Disorders; 2005) criteria (Manual of the?American Academy of Sleep Medicine?) -Both Sex, age< 70 years -Written Consensus
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - MMSE<24 -Side intolerable effects referred to Rivastigmine -Gastric ulcer -Epileptic seizures -Urinary Occlusion -Sinus-node disease -Cardiac Conduction Defects (sino-atrial block; atrioventricular block) -Bronchopneumopathy Chronic obstructive (BPCO)

研究者

发起方
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

相似试验